Further evaluation of the local lymph node assay in the final phase of an international collaborative trial.

E.I. du Pont de Nemours, Inc. Haskell Laboratory, Newark, DE 19711-0050, USA.
Toxicology (Impact Factor: 3.75). 05/1996; 108(1-2):141-52. DOI: 10.1016/0300-483X(95)03279-O
Source: PubMed

ABSTRACT The local lymph node assay (LLNA) is a method used for the prospective identification in mice of chemicals that have the potential to cause skin sensitization. We report here the results of the second and final phase of an international trial in which the performance of the assay has been evaluated using seven test materials in five independent laboratories. The additional chemicals examined here included compounds which are considered less potent allergens than some of those tested in the first phase of the investigation, and includes hexylcinnamic aldehyde (HCA), a chemical recommended by the Organization for Economic Cooperation and Development (OECD) as a positive control for skin sensitization studies. In each laboratory all skin sensitizing chemicals examined (2,4-dinitrochlorobenzene {DNCB}, HCA, oxazolone, isoeugenal and eugenol) elicited positive responses of comparable magnitude as judged by the derived lowest concentration of test chemical required to elicit a 3-fold or greater increase in the proliferative activity of draining lymph node cells compared with vehicle-treated controls. We observed that sodium lauryl sulphate, considered to be a non-sensitizing skin irritant, also induced a positive response in the assay. Para-aminobenzoic acid (pABA), a nonsensitizing chemical, was negative at all test concentrations in each laboratory. Some laboratories incorporated minor modifications into the standard assay procedure, including the evaluation of lymph nodes pooled from individual mice rather than treatment groups and the use of statistical analyses. The use of statistics did not markedly change the determination of the lowest concentration yielding a positive response. These data confirm that the local lymph node assay is robust and yields equivalent results when performed independently.

1 Bookmark
  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: The Direct Peptide Reactivity Assay (DPRA) was developed as an alternative simple and versatile method for predicting skin sensitization. Here, we describe a novel Amino acids Derivatives Reactivity Assay (ADRA) involving 2 amino acid derivatives: N-(2-(1-naphthyl)acetyl)-L-cysteine (NAC) and α-N-(2-(1-naphthyl)acetyl)-L-lysine (NAL), in which each amino-terminal residue is introduced into a naphthalene ring. ADRA measurements were conducted at 281 nm, which improved baseline stability, and were less influenced by other substances in the reaction solutions than DPRA measurements that are conducted at 220 nm.
    Journal of Pharmacological and Toxicological Methods 06/2014; 70(1). DOI:10.1016/j.vascn.2014.06.001 · 2.15 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The risk of contact sensitisation is a major consideration in the development of new formulations for personal care products. However, developing a mechanistic approach for non-animal risk assessment requires further understanding of haptenation of skin proteins by sensitising chemicals, which is the molecular initiating event causative of skin sensitisation. The non-stoichiometric nature of protein haptenation results in relatively low levels of modification, often of low abundant proteins, presenting a major challenge for their assignment in complex biological matrices such as skin. Instrumental advances over the last few years have led to a considerable increase in sensitivity of mass spectrometry (MS) techniques. We have combined these advancements with a novel dual-labeling/LC-MS(E) approach to provide an in-depth direct comparison of human serum albumin (HSA) haptenation by 2,4-dichloro-1-nitrobenezene (DNCB), 5-chloro-2-methyl-4-isothiazolin-3-one (MCI), trans-cinnamaldehyde and 6-methyl coumarin. These data have revealed novel insights into the differences in protein haptenation between sensitisers with different reaction mechanisms and sensitising potency; the extreme sensitisers DNCB and MCI were shown to modify a greater number of nucleophilic sites than the moderate sensitiser cinnamaldehyde; and the weak/non-sensitiser 6-methyl coumarin was restricted to only a single nucleophilic residue within HSA. The evaluation of this dual labelling/LC-MS(E) approach using HSA as a model protein has also demonstrated that this strategy could be applied to studying global haptenation in complex mixtures of skin related proteins by different chemicals.
    Toxicological Sciences 08/2014; 142(1). DOI:10.1093/toxsci/kfu168 · 4.48 Impact Factor